Extended release oxybutynin is more effective than tolterodine for paediatric patients with non-neurogenic diurnal urinary incontinence

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1373, 2003-01, pp. : 21-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-Effectiveness Analysis of Extended-Release Formulations of Oxybutynin and Tolterodine for the Management of Urge Incontinence

By Hughes Dyfrig A.  

PharmacoEconomics, Vol. 22, Iss. 16, 2004-01 ,pp. : 1047-1059

Adis International

Access to resources Recommend Favorite

Oxybutynin: tablets, syrup effective in paediatric neurogenic bladder

By  

Inpharma, Vol. 1, Iss. 1477, 2005-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Oxybutynin Extended Release and Tolterodine Immediate Release: A Health Economic Comparison

By Getsios D.  

Clinical Drug Investigation, Vol. 24, Iss. 2, 2004-01 ,pp. : 81-88

Adis International

Access to resources Recommend Favorite

Effect of Antacid on the Pharmacokinetics of Extended-Release Formulations of Tolterodine and Oxybutynin

By Gayatri Sathyan  

Clinical Pharmacokinetics, Vol. 43, Iss. 14, 2004-01 ,pp. : 1059-1068

Adis International

Access to resources Recommend Favorite

Extended-release oxybutynin an effective option in overactive bladder

By  

Inpharma, Vol. 1, Iss. 1303, 2001-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite